.svg){kind=small}
Oct-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Stigma Grow has shown notable performance in the Alberta market, particularly in the Concentrates category, where it improved its ranking from 17th in July to 12th by October 2025. This upward movement is accompanied by a steady increase in sales, indicating growing consumer preference and market penetration. However, in the Flower category, the brand's presence is less prominent, with a brief appearance in July and a return in October, suggesting challenges in maintaining a consistent market position. In the Capsules category, despite a slight drop in sales, Stigma Grow has managed to maintain a stable ranking, highlighting resilience in this segment.
In British Columbia, Stigma Grow's performance in the Capsules category has been consistent, holding the 9th position in both August and October. This stability contrasts with the fluctuating rankings in the Concentrates category, where the brand dropped from 18th in July to 27th in October, accompanied by a decline in sales. The Ontario market presents a mixed picture; while the Capsules category shows a promising rise back to 9th position in October, the Concentrates category lacks a notable presence, as indicated by the absence of a top 30 ranking. This varied performance across provinces and categories reflects both the brand's strengths and areas for potential growth.
Competitive Landscape
In the Alberta concentrates market, Stigma Grow has shown a positive trend in its ranking and sales over the past few months. Starting from a rank of 17 in July 2025, Stigma Grow improved its position to 12 by October 2025, indicating a consistent upward trajectory. This improvement is notable when compared to competitors like Roilty Concentrates, which experienced a decline from rank 4 in July to rank 10 in October, and Nugz (Canada), which saw fluctuations, ending at rank 13 in October. Meanwhile, GORILLA GARDEN CRAFT CANNABIS & EXTRACTS had a volatile performance, peaking at rank 5 in September but dropping to 14 in October. The Goo! also showed variability, ending at rank 9 in October. Stigma Grow's consistent improvement in both rank and sales suggests a growing consumer preference and effective market strategies, positioning it favorably against its competitors in the Alberta concentrates market.
Notable Products
In October 2025, Phoenix Tears RSO (1g) continued its reign as the top-performing product for Stigma Grow, maintaining its number one rank from the previous three months, with sales reaching 3659 units. The Indica RSO Capsules 25-Pack (250mg) held steady at the second position, consistent with its ranking since August 2025, showing a slight increase in sales compared to September. CBD Softgels 15-Pack (750mg CBD) remained in third place, demonstrating a stable performance across the months. Phoenix Tears Resin (1g) improved its ranking from fifth in September to fourth in October, indicating a positive shift in consumer preference. Meanwhile, Rippin Razz 2.0 Shatter (4g) experienced a slight drop from fourth to fifth place, reflecting a decrease in sales volume.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
